Design of Y-2 Receptor Selective and Proteolytically Stable PYY3-36 Analogues
In recent years peptide YY (PYY) has attracted attention within the area of diabetes and obesity due to its involvement in food intake regulation and glucose homeostasis. It is well-known that PYY1-36 is rapidly cleaved by dipeptidyl peptidase-4 to the more Y2 receptor selective analogue PYY3-36, wh...
Saved in:
Published in | Journal of medicinal chemistry Vol. 61; no. 23; pp. 10519 - 10530 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
Amer Chemical Soc
13.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In recent years peptide YY (PYY) has attracted attention within the area of diabetes and obesity due to its involvement in food intake regulation and glucose homeostasis. It is well-known that PYY1-36 is rapidly cleaved by dipeptidyl peptidase-4 to the more Y2 receptor selective analogue PYY3-36, which is further cleaved to the inactive analogue PYY3-34. In order to improve the selectivity and proteolytic stability of the C-terminus, we synthesized several analogues incorporating N-methyl amino acids or beta-homo amino acids and other non-natural amino acids. These were tested against all four NPY receptors, and highly potent and Y-2 receptor selective analogues were identified by combining a tryptophan residue in position 30 with either N-methyl or beta-homo arginine in position 35. We also identified an analogue with a MeGln(34) substitution that surprisingly displayed high affinity toward all four receptors. In addition, these analogues displayed improved stability toward C-terminal proteolysis compared to native PYY3-36. |
---|---|
ISSN: | 0022-2623 1520-4804 |
DOI: | 10.1021/acs.jmedchem.8b01046 |